Pfizer: Weaknesses and Threats
Even the strongest companies are not immune to problems. Internally and externally, Pfizer has to deal with negative factors on a daily basis. They range from minor routines like keeping enough pencils in the secretaries' supply closet, to major re-structuring strategies such as mergers. Since every company is faced with these decisions, the way the company responds to each situation is what determines if they will continue to prosper or if they are committing to their demise. This paper will touch on some of the major weaknesses and potential threats Pfizer's human pharmaceutical division is currently in the process of dealing with.Like all other pharmaceutical companies, Pfizer constantly battles with decisions about inventory. When a small drugstore or pharmacy orders drugs to stock their shelves, usually it is in relatively small quantities that will turnover in a matter of months then they reorder. This way they don't risk losing inventory to expired medicine when demand is low. On the other hand, large drug producers such as Pfizer, have to keep warehouses full of medicines ready to ship. If something decreases the drug demand, the inve
Then they increased their bid to 82. The merger scare with Merck was the figment of a creative imagination, however, in early November, Pfizer shocked everyone with the hostile takeover bid for Warner-Lambert. Pfizer's hostile move surprised many in the industry including analysts. However, not acknowledging it can be far worse. Obviously once they lose the monopoly on a drug to a much cheaper generic, they lose the profits associated with the monopolistic marker share. FDA Panels Every drug has to undergo FDA approval before it can be marketed to the consumers. and American Home Products Corporation that announced their plan for a friendly $70 billion merger. Pfizer has been at the center of several such rumors. Consider the case of one of Pfizer's ex-competitors, Pharmax. Some companies try to counter the loss of market share by producing their own versions of a drug. Pfizer must also change the name of the drug. The FDA approval begins with a potential new drug that has to be proven through rigorous testing and testing and testing. After a drug is okayed, it is then observed indefinitely afterwards to ensure the public's safety in association with the drug. Most likely a simple revision in labeling will be all that's necessary but acknowledgement opens the door to suit by those who may have already been affected that had no prior warning about the potential harm.
Common topics in this essay:
Weaknesses Inventory,
FDA Panels,
Trovan Ltd,
William Steere,
HMO's Pfizer,
Weaknesses Threats,
Consider Pfizer's,
Johnson Glaxo-Wellcome,
Products Corporation,
Department Justice,
fda approval,
rumors merger,
insurance companies,
ceo william steere,
pharmaceutical companies,
company facing,
william steere,
pharmaceutical industry,
testing testing,
warner-lambert co,
takeover bid,
|
Acceptance Essays
